Literature DB >> 21573915

The critically ill asthmatic--from ICU to discharge.

Samuel Louie1, Brian M Morrissey, Nicholas J Kenyon, Timothy E Albertson, Mark Avdalovic.   

Abstract

Status asthmaticus (SA) is defined as an acute, severe asthma exacerbation that does not respond readily to initial intensive therapy, while near-fatal asthma (NFA) refers loosely to a status asthmaticus attack that progresses to respiratory failure. The in-hospital mortality rate for all asthmatics is between 1% to 5%, but for critically ill asthmatics that require intubation the mortality rate is between 10% to 25% primarily from anoxia and cardiopulmonary arrest. Timely evaluation and treatment in the clinic, emergency room, or ultimately the intensive care unit (ICU) can prevent the morbidity and mortality associated with respiratory failure. Fatal asthma occurs from cardiopulmonary arrest, cerebral anoxia, or a complication of treatments, e.g., barotraumas, and ventilator-associated pneumonia. Mortality is highest in African-Americans, Puerto Rican-Americans, Cuban-Americans, women, and persons aged ≥ 65 years. Critical care physicians or intensivists must be skilled in managing the critically ill asthmatics with respiratory failure and knowledgeable about the few but potentially serious complications associated with mechanical ventilation. Bronchodilator and anti-inflammatory medications remain the standard therapies for managing SA and NFA patients in the ICU. NFA patients on mechanical ventilation require modes that allow for prolonged expiratory time and reverse the dynamic hyperinflation associated with the attack. Several adjuncts to mechanical ventilation, including heliox, general anesthesia, and extra-corporeal carbon dioxide removal, can be used as life-saving measures in extreme cases. Coordination of discharge and follow-up care can safely reduce the length of hospital stay and prevent future attacks of status asthmaticus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21573915     DOI: 10.1007/s12016-011-8274-y

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  83 in total

1.  Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations.

Authors:  Trudy B Pendergraft; Richard H Stanford; Richard Beasley; David A Stempel; Craig Roberts; Trent McLaughlin
Journal:  Ann Allergy Asthma Immunol       Date:  2004-07       Impact factor: 6.347

2.  Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma.

Authors:  M Saetta; A Di Stefano; C Rosina; G Thiene; L M Fabbri
Journal:  Am Rev Respir Dis       Date:  1991-01

3.  The effect of heliox in acute severe asthma: a randomized controlled trial.

Authors:  J E Kass; C A Terregino
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

4.  Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids.

Authors:  S E Wenzel; S J Szefler; D Y Leung; S I Sloan; M D Rex; R J Martin
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

5.  Risk factors for hydrocortisone myopathy in acute severe asthma.

Authors:  C D Shee
Journal:  Respir Med       Date:  1990-05       Impact factor: 3.415

6.  School examinations enhance airway inflammation to antigen challenge.

Authors:  Lin Ying Liu; Christopher L Coe; Cheri A Swenson; Elizabeth A Kelly; Hirohito Kita; William W Busse
Journal:  Am J Respir Crit Care Med       Date:  2002-04-15       Impact factor: 21.405

7.  A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.

Authors:  Carlos A Camargo; Deborah M Gurner; Howard A Smithline; Rocio Chapela; Leonardo M Fabbri; Stuart A Green; Marie-Pierre Malice; Catherine Legrand; S Balachandra Dass; Barbara A Knorr; Theodore F Reiss
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

8.  Difficult-to-control asthma in adults.

Authors:  Forest H Mealey; Nicholas J Kenyon; Mark V Avdalovic; Samuel Louie
Journal:  Am J Med       Date:  2007-09       Impact factor: 4.965

9.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245

10.  Ipratropium treatment of acute airways disease.

Authors:  Gregory M Peterson; Peter J Boyles; Martin D Bleasel; Janet H Vial
Journal:  Ann Pharmacother       Date:  2003-03       Impact factor: 3.154

View more
  15 in total

Review 1.  Immunobiology of critical pediatric asthma.

Authors:  Stacey Galowitz; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

Review 2.  Critical asthma syndrome in the ICU.

Authors:  Michael Schivo; Chinh Phan; Samuel Louie; Richart W Harper
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

Review 3.  Management of critical asthma syndrome during pregnancy.

Authors:  Andrew L Chan; Maya M Juarez; Nisha Gidwani; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

Review 4.  Evaluation and treatment of critical asthma syndrome in children.

Authors:  Alexander Wade; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

5.  Sevoflurane Prevents Airway Remodeling via Downregulation of VEGF and TGF-β1 in Mice with OVA-Induced Chronic Airway Inflammation.

Authors:  Qi-Ying Shen; Ling Wu; Chuan-Sheng Wei; Yan-Nan Zhou; Hui-Mei Wu
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

6.  Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response.

Authors:  Qinglin Zha; Seqi Lin; Chi Zhang; Christopher Chang; Hanrong Xue; Cheng Lu; Miao Jiang; Yan Liu; Zuke Xiao; Weiyou Liu; Yunfei Shang; Jianjian Chen; Minyong Wen; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-03       Impact factor: 2.629

7.  Heliox in the treatment of status asthmaticus: case reports.

Authors:  Inês Carvalho; Sara Querido; Joana Silvestre; Pedro Póvoa
Journal:  Rev Bras Ter Intensiva       Date:  2016 Jan-Mar

8.  Noninvasive ventilation in life-threatening asthma: A case series.

Authors:  Andrew Miller; Dean A VanHart; Michael A Gentile
Journal:  Can J Respir Ther       Date:  2017-08-01

9.  Nitric oxide and its metabolites in the critical phase of illness: rapid biomarkers in the making.

Authors:  Asad I Mian; Mayank Aranke; Nathan S Bryan
Journal:  Open Biochem J       Date:  2013-03-08

10.  Asthma changes at a pediatric intensive care unit after 10 years: Observational study.

Authors:  Ayman A Al-Eyadhy; Mohamad-Hani Temsah; Ali A N Alhaboob; Abdulmalik K Aldubayan; Nasser A Almousa; Abdulrahman M Alsharidah; Mohammed I Alangari; Abdulrahman M Alshaya
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.